A new randomized controlled trial has found promising evidence that the smoking cessation medication varenicline ...
Combined exercise improves blood sugar levels and inflammation without the need for medication in sedentary adults.
In sweeping changes to the childhood vaccine schedule, the Centers for Disease Control and Prevention no longer recommends ...
The World Health Organisation will this year start to work with scientists and drug developers to gather more information ...
AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor being developed for the management of fibromyalgia. Esreboxetine is the SS-enantiomer of racemic reboxetine.
The review looked at more than three dozen studies and found no evidence that acetaminophen increased the risk of ...
When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides.
4hon MSNOpinion
Could ChatGPT convince you to buy something? Threat of manipulation looms as AI companies gear up to sell ads
The functionality of ChatGPT Search and its Atlas browser is not really new. Meta, commercial AI competitor Perplexity and ...
Researchers developed TLC-2716, a liver- and gut-targeted drug that selectively reduced LXR activity, lowering triglycerides, ...
News Medical on MSN
Brain stimulation device cleared for ADHD in the US is overall safe but ineffective
Evidence from a new large UK multicentre trial is challenging the results from a previous smaller US trial that led to the ...
News Medical on MSN
First-in-human drug trial lowers high blood fats
In a Phase 1 clinical study, researchers led by EPFL and their partners report that a new liver- and gut-targeted oral drug ...
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results